REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19
Weinreich DM, et al.〔N Engl J Med. 2021 Jan 21;384(3):238-251〕（査読済み）
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Wang P, et al.〔Nature. 2021 Mar 8〕（査読済み）
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group〔medRxiv 2021 Jun 16〕（査読前）
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial